摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,6-二氟双环[3.1.0]己-3-胺盐酸盐 | 1955524-13-6

中文名称
6,6-二氟双环[3.1.0]己-3-胺盐酸盐
中文别名
——
英文名称
6,6-difluorobicyclo[3.1.0]hexan-3-amine hydrochloride
英文别名
6,6-difluorobicyclo[3.1.0]hexan-3-amine;hydrochloride
6,6-二氟双环[3.1.0]己-3-胺盐酸盐化学式
CAS
1955524-13-6
化学式
C6H9F2N*ClH
mdl
——
分子量
169.602
InChiKey
DDXVVYHUUNFLFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.41
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    26
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
    申请人:Nurix Therapeutics, Inc.
    公开号:US11530229B2
    公开(公告)日:2022-12-20
    Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.
    本发明公开了用于抑制泛素蛋白酶体途径中的 E3 酶 Cbl-b 的化合物、组合物和方法。这些化合物、组合物和方法可用于调节免疫系统,治疗免疫系统可调节的疾病,以及体内、体外或体外细胞的治疗。还公开了包含 Cbl-b 抑制剂和癌症疫苗的药物组合物,以及使用 Cbl-b 抑制剂和癌症疫苗治疗癌症的方法;以及包含 Cbl-b 抑制剂和溶瘤病毒的药物组合物,以及使用 Cbl-b 抑制剂和溶瘤病毒治疗癌症的方法。
  • CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
    申请人:Nurix Therapeutics, Inc.
    公开号:US20210053986A1
    公开(公告)日:2021-02-25
    Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.
  • [EN] CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF<br/>[FR] COMPOSÉS CYANO-CYCLOBUTYLE POUR L'INHIBITION DE CBL-B ET LEURS UTILISATIONS
    申请人:NURIX THERAPEUTICS INC
    公开号:WO2020236654A1
    公开(公告)日:2020-11-26
    Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.
查看更多